Clinical trial
Exhale (R) Stent for Emphysema
NCT00207337 · Broncus Technologies, Industry · Completed
Key facts
| NCT number | NCT00207337 |
|---|---|
| Title | Exhale (R) Stent for Emphysema |
| Official title | A Prospective Feasibility Study to Evaluate the Safety and Performance of the Exhale(R) Drug-Eluting Stent System in Patients With Emphysema |
| Lead sponsor | Broncus Technologies, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Emphysema |
| Intervention type | Device |
| Interventions | Exhale Drug-Eluting Stent |
| Enrollment | 60 |
| Start date | Jul 1, 2004 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Jan 23, 2008 |
| Countries | Australia, Brazil, Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: